Treatment of steroid-resistant focal segmental glomerulosclerosis with rituximab: A case report and review of literature

Various immunomodulating agents have been tried for the treatment of steroid-resistant focal segmental glomerulosclerosis (FSGS) in the native kidney. A few case series and small studies have reported mixed results with the use of Rituximab for this indication. We report on the case of a 76-year-old...

Full description

Bibliographic Details
Main Authors: Mohamed Hasham Varwani, Ahmed Sokwala
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=5;spage=1175;epage=1179;aulast=Varwani